Carlos Ribeiro Diniz

Title: Innovations of Carlos Ribeiro Diniz

Introduction

Carlos Ribeiro Diniz is a notable inventor based in Minas Gerais, Brazil. He has made significant contributions to the field of pharmacology, particularly in the development of hypotensive agents derived from scorpion peptides. His work has the potential to impact the treatment of hypertension, a prevalent health issue worldwide.

Latest Patents

Diniz holds a patent for his invention titled "Scorpion peptide as hypotensive agent." This invention provides isoforms from a peptide family belonging to South American scorpions that act as hypotensive agents by potentiating Bradykinin. The peptide was first isolated from venom and demonstrated strong and long-lasting hypotensive activity when tested in rats. The initial peptide was named TsHpt-I (Hypotensin-I), and three additional highly similar isoforms were identified, named TsHpt-II, TsHpt-III, and TsHpt-IV.

Career Highlights

Carlos Ribeiro Diniz is affiliated with the Universidade Federal de Minas Gerais, where he conducts research and develops innovative solutions in the field of medicine. His work focuses on the therapeutic applications of peptides, particularly in managing blood pressure.

Collaborations

Diniz has collaborated with several colleagues, including Maria Elena De Lima Perez-Garcia and Robson Augusto Souza Dos Santos. These collaborations have contributed to the advancement of his research and the exploration of new therapeutic avenues.

Conclusion

Carlos Ribeiro Diniz is a pioneering inventor whose work on scorpion peptides has the potential to revolutionize the treatment of hypertension. His contributions to pharmacology highlight the importance of innovative research in addressing global health challenges.